Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARRIS - Another partner -- Ignore unavailable to you. Want to Upgrade?

To: CYBERKEN who wrote (294)	12/8/1997 8:21:00 PM
From: David Bogdanoff	Read Replies (1) \| Respond to of 353

The bailer-outers have left us with a buying opp. The point of the merger was to add value through vertical integration of technologies. There should be synergistic effects. It is not a matter of whose product pipeline is closer to market. It is creating new integrated research capabilities which will bring in new research contracts. The other comments about difficulties with two separate facilities show how little vision and understanding of the research business these faint of heart investors have. The most succesful companies (eg GE) have world-wide facilities and conduct projects on a 24 hr. round the world basis. Give me a break. David

To: CYBERKEN who wrote (294)	12/8/1997 8:55:00 PM
From: Andrew H	Read Replies (2) \| Respond to of 353

>>Perhaps the disaffected have already mostly voted with their feet. << One would think so, but then how does one explain the big rally on the announcement of today's news? First big rally in quite a while. Unfortunately, sometimes anything new upsets and frightens people, even when its for the better. Ken, don't they call those people conservatives? (:>)